Cansino Biologics Stock Market Value
| CASBF Stock | USD 3.90 0.00 0.00% |
| Symbol | CanSino |
CanSino Biologics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CanSino Biologics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CanSino Biologics.
| 11/28/2023 |
| 11/22/2024 |
If you would invest 0.00 in CanSino Biologics on November 28, 2023 and sell it all today you would earn a total of 0.00 from holding CanSino Biologics or generate 0.0% return on investment in CanSino Biologics over 360 days. CanSino Biologics is related to or competes with CbdMD, Evolus, Akanda Corp, Biofrontera, Collegium Pharmaceutical, ANI Pharmaceuticals, and INC Research. CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the Peoples Republic of China More
CanSino Biologics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CanSino Biologics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CanSino Biologics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1249 | |||
| Maximum Drawdown | 47.88 | |||
| Potential Upside | 11.11 |
CanSino Biologics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CanSino Biologics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CanSino Biologics' standard deviation. In reality, there are many statistical measures that can use CanSino Biologics historical prices to predict the future CanSino Biologics' volatility.| Risk Adjusted Performance | 0.1136 | |||
| Jensen Alpha | 1.02 | |||
| Total Risk Alpha | 0.1639 | |||
| Treynor Ratio | (0.94) |
CanSino Biologics Backtested Returns
CanSino Biologics is very risky given 3 months investment horizon. CanSino Biologics secures Sharpe Ratio (or Efficiency) of 0.19, which signifies that the company had a 0.19% return per unit of risk over the last 3 months. We have analyzed eighteen different technical indicators, which can help you to evaluate if expected returns of 1.27% are justified by taking the suggested risk. Use CanSino Biologics Risk Adjusted Performance of 0.1136, standard deviation of 6.81, and Mean Deviation of 2.82 to evaluate company specific risk that cannot be diversified away. CanSino Biologics holds a performance score of 15 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -0.99, which signifies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning CanSino Biologics are expected to decrease slowly. On the other hand, during market turmoil, CanSino Biologics is expected to outperform it slightly. Use CanSino Biologics maximum drawdown, as well as the relationship between the kurtosis and day typical price , to analyze future returns on CanSino Biologics.
Auto-correlation | -0.16 |
Insignificant reverse predictability
CanSino Biologics has insignificant reverse predictability. Overlapping area represents the amount of predictability between CanSino Biologics time series from 28th of November 2023 to 26th of May 2024 and 26th of May 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CanSino Biologics price movement. The serial correlation of -0.16 indicates that over 16.0% of current CanSino Biologics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.16 | |
| Spearman Rank Test | -0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 0.38 |
CanSino Biologics lagged returns against current returns
Autocorrelation, which is CanSino Biologics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CanSino Biologics' pink sheet expected returns. We can calculate the autocorrelation of CanSino Biologics returns to help us make a trade decision. For example, suppose you find that CanSino Biologics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
CanSino Biologics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CanSino Biologics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CanSino Biologics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CanSino Biologics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
CanSino Biologics Lagged Returns
When evaluating CanSino Biologics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CanSino Biologics pink sheet have on its future price. CanSino Biologics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CanSino Biologics autocorrelation shows the relationship between CanSino Biologics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in CanSino Biologics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in CanSino Pink Sheet
CanSino Biologics financial ratios help investors to determine whether CanSino Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CanSino with respect to the benefits of owning CanSino Biologics security.